Kala Pharmaceuticals, Inc. (KALA)

USD 3.22

(3.21%)

Total Liabilities Summary of Kala Pharmaceuticals, Inc.

  • Kala Pharmaceuticals, Inc.'s latest annual total liabilities in 2023 was 48.44 Million USD , down -28.6% from previous year.
  • Kala Pharmaceuticals, Inc.'s latest quarterly total liabilities in 2024 Q2 was 47.88 Million USD , up 3.27% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported annual total liabilities of 67.84 Million USD in 2022, down -44.67% from previous year.
  • Kala Pharmaceuticals, Inc. reported annual total liabilities of 122.62 Million USD in 2021, up 0.83% from previous year.
  • Kala Pharmaceuticals, Inc. reported quarterly total liabilities of 46.37 Million USD for 2024 Q1, down -4.28% from previous quarter.
  • Kala Pharmaceuticals, Inc. reported quarterly total liabilities of 49 Million USD for 2023 Q2, up 0.5% from previous quarter.

Annual Total Liabilities Chart of Kala Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Total Liabilities of Kala Pharmaceuticals, Inc. (2023 - 2015)

Year Total Liabilities Total Liabilities Growth
2023 48.44 Million USD -28.6%
2022 67.84 Million USD -44.67%
2021 122.62 Million USD 0.83%
2020 121.61 Million USD -2.42%
2019 124.63 Million USD 7.46%
2018 115.97 Million USD 338.42%
2017 26.45 Million USD -80.27%
2016 134.09 Million USD 105.94%
2015 65.11 Million USD 0.0%

Peer Total Liabilities Comparison of Kala Pharmaceuticals, Inc.

Name Total Liabilities Total Liabilities Difference
Intra-Cellular Therapies, Inc. 136.87 Million USD 64.605%
PainReform Ltd. 2.69 Million USD -1700.26%
Alvotech 1.88 Billion USD 97.427%
Collegium Pharmaceutical, Inc. 947.87 Million USD 94.889%
ANI Pharmaceuticals, Inc. 471.67 Million USD 89.729%
Aquestive Therapeutics, Inc. 163.9 Million USD 70.443%
Journey Medical Corporation 56.49 Million USD 14.255%
Dynavax Technologies Corporation 375.02 Million USD 87.082%
Esperion Therapeutics, Inc. 660.79 Million USD 92.669%
Bright Green Corporation 6.43 Million USD -652.473%
Pacira BioSciences, Inc. 704.25 Million USD 93.121%
Embecta Corp. 2.03 Billion USD 97.621%
Sunshine Biopharma, Inc. 6.13 Million USD -689.058%
Sunshine Biopharma, Inc. 6.13 Million USD -689.058%
SCYNEXIS, Inc. 55.45 Million USD 12.633%
Petros Pharmaceuticals, Inc. 21.31 Million USD -127.273%
Silver Spike Investment Corp. 3 Million USD -1509.559%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -426.77%
Alpha Teknova, Inc. 38.55 Million USD -25.665%
Safety Shot Inc 3.89 Million USD -1144.719%
Procaps Group, S.A. 462.06 Million USD 89.516%
Cosmos Health Inc. 30.25 Million USD -60.135%
Theratechnologies Inc. 98.63 Million USD 50.887%
Harrow Health, Inc. 241.75 Million USD 79.961%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -453.278%
Biofrontera Inc. 23.13 Million USD -109.365%
DURECT Corporation 30.4 Million USD -59.327%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 90.062%
Cronos Group Inc. 43.73 Million USD -10.767%
OptiNose, Inc. 194.33 Million USD 75.071%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 94.073%
RedHill Biopharma Ltd. 20.97 Million USD -130.931%
Organogenesis Holdings Inc. 181.36 Million USD 73.288%
Guardion Health Sciences, Inc. 3.77 Million USD -1184.286%
Cumberland Pharmaceuticals Inc. 52.51 Million USD 7.752%
Radius Health, Inc. 804.29 Million USD 93.977%
Universe Pharmaceuticals INC 13.75 Million USD -252.216%
ProPhase Labs, Inc. 42.54 Million USD -13.87%
Phibro Animal Health Corporation 725.54 Million USD 93.323%
Procaps Group S.A. 462.06 Million USD 89.516%
TherapeuticsMD, Inc. 14.02 Million USD -245.493%
Viatris Inc. 27.21 Billion USD 99.822%
Rockwell Medical, Inc. 30.88 Million USD -56.871%
Aytu BioPharma, Inc. 90.37 Million USD 46.398%
SIGA Technologies, Inc. 57.97 Million USD 16.441%
Tilray Brands, Inc. 892.11 Million USD 94.57%
Lifecore Biomedical, Inc. 219.8 Million USD 77.96%
Shineco, Inc. 47.6 Million USD -1.772%
PetIQ, Inc. 645.22 Million USD 92.492%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -21969.409%
Incannex Healthcare Limited 5.83 Million USD -730.961%
Neurocrine Biosciences, Inc. 1.01 Billion USD 95.248%
Alimera Sciences, Inc. 107.35 Million USD 54.874%
Assertio Holdings, Inc. 148.41 Million USD 67.359%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -2455.163%
Clever Leaves Holdings Inc. 7.02 Million USD -589.51%
Cyclo Therapeutics, Inc. 8.49 Million USD -470.577%
Avadel Pharmaceuticals plc 173.38 Million USD 72.06%
Hempacco Co., Inc. 18.82 Million USD -157.379%
Talphera, Inc. 6.29 Million USD -670.191%
Alvotech 1.88 Billion USD 97.427%
Eagle Pharmaceuticals, Inc. 172.6 Million USD 71.932%
Lantheus Holdings, Inc. 835.25 Million USD 94.2%
Currenc Group, Inc. 177.67 Million USD 72.734%
Kamada Ltd. 109.96 Million USD 55.946%
Indivior PLC 1.95 Billion USD 97.517%
Evoke Pharma, Inc. 9.64 Million USD -402.12%
Flora Growth Corp. 17.22 Million USD -181.297%
Cyclo Therapeutics, Inc. 8.49 Million USD -470.577%
Evolus, Inc. 209.68 Million USD 76.897%
HUTCHMED (China) Limited 536.38 Million USD 90.968%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 94.454%
Akanda Corp. 12.66 Million USD -282.394%